» Articles » PMID: 20417621

MicroRNA-1285 Inhibits the Expression of P53 by Directly Targeting Its 3' Untranslated Region

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2010 Apr 27
PMID 20417621
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

The well-known tumor suppressor p53 plays critical roles in the modulation of multiple cellular processes. The regulation of p53 is complicated and remains elusive. In this study, we used a high-throughput luciferase reporter screen to demonstrate that p53 can be regulated by microRNA-1285 (miR-1285). Notably, miR-612, which has the same seed sequence as miR-1285, cannot bind to the 3' untranslated region (3' UTR) of p53. Mutational analyses confirmed that the 3' UTR of p53 mRNA contains two miR-1285 target sites, which are nearly perfectly complementary to the mature miR-1285 sequence. Ectopic expression of miR-1285 inhibits expression of p53 mRNA and protein. In contrast, silencing of miR-1285 increases p53 expression. Furthermore, miR-1285 inhibits the transcription of p21, a master gene downstream of p53. In conclusion, our findings provide the first evidence that miR-1285 directly regulates the expression of p53 by directly targeting its 3' UTR.

Citing Articles

Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as Potential New Biomarkers in Patients with Diabetes Mellitus and Pancreatic Adenocarcinoma.

Kolokotronis T, Majchrzak-Stiller B, Buchholz M, Mense V, Strotmann J, Peters I Cancers (Basel). 2024; 16(15).

PMID: 39123454 PMC: 11311671. DOI: 10.3390/cancers16152726.


How MicroRNAs Command the Battle against Cancer.

Wu H, Leng S, Sergi C, Leng R Int J Mol Sci. 2024; 25(11).

PMID: 38892054 PMC: 11172831. DOI: 10.3390/ijms25115865.


Analysis of the p53/microRNA Network in Cancer.

Kaller M, Hunten S, Siemens H, Hermeking H Adv Exp Med Biol. 2022; 1385:187-228.

PMID: 36352215 DOI: 10.1007/978-3-031-08356-3_7.


Cell cycle associated miRNAs as target and therapeutics in lung cancer treatment.

Fariha A, Hami I, Tonmoy M, Akter S, Al Reza H, Bahadur N Heliyon. 2022; 8(10):e11081.

PMID: 36303933 PMC: 9593298. DOI: 10.1016/j.heliyon.2022.e11081.


Circulating miRNAs in Breast Cancer Diagnosis and Prognosis.

Cardinali B, Tasso R, Piccioli P, Ciferri M, Quarto R, Del Mastro L Cancers (Basel). 2022; 14(9).

PMID: 35565446 PMC: 9101355. DOI: 10.3390/cancers14092317.